THE USE OF REAL-WORLD DATA IN DECISION MAKING FOR ONCOLOGY: A REVIEW OF RECENT HEALTH TECHNOLOGY APPRAISALS IN THE UNITED KINGDOM

被引：0
|
作者：
Koufopoulou, M. [1 ]
Wissinger, E. [2 ]
Oladapo, T. [1 ]
Stewart, F. [3 ]
Depalma, S. [3 ]
Devani, D. [2 ]
Rangi, N. D. [1 ]
Fusco, N. [2 ]
机构：
[1] AmerisourceBergen, London, England
[2] AmerisourceBergen, Carollton, TX USA
[3] AmerisourceBergen, Hannover, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA24
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [31] Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology
    Wheaton, Lorna
    Bujkiewicz, Sylwia
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2025, 41 (01)
  • [32] Development of audit readiness considerations of real-world data for use in regulatory decision-making
    Atzinger, Christopher B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 411 - 411
  • [33] The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A Review
    Che, Yoojung
    Duffield, Stephen
    Gomes, Manuel
    PHARMACOECONOMICS, 2025, 43 (02) : 123 - 131
  • [34] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [35] Real-World Data Analytics Fit for Regulatory Decision-Making
    Schneeweiss, Sebastian
    Glynn, Robert J.
    AMERICAN JOURNAL OF LAW & MEDICINE, 2018, 44 (2-3) : 197 - 216
  • [36] USE OF REAL-WORLD EVIDENCE IN CLINICAL DECISION MAKING BY COMMUNITY ONCOLOGISTS
    Kish, J.
    Feinberg, B.
    Hua, D.
    Tchafa, A.
    Smith, Y.
    Klink, A.
    Nabhan, C.
    VALUE IN HEALTH, 2018, 21 : S48 - S48
  • [37] REAL WORLD DATA: A TOOL FOR DECISION MAKING IN HEALTH CARE
    Mussolino, F.
    Vaz, P. V.
    Pepe, C.
    Junqueira, M.
    VALUE IN HEALTH, 2014, 17 (03) : A123 - A123
  • [38] Real-world outcomes with palbociclib, abemaciclib and ribociclib; experience of a tertiary oncology centre in the United Kingdom
    Wang, Lei
    Ibrahim, Muhammad
    Neal, Anthony
    CANCER RESEARCH, 2022, 82 (04)
  • [39] Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review
    Jansen, Marieke S.
    Dekkers, Olaf M.
    le Cessie, Saskia
    Hooft, Lotty
    Gardarsdottir, Helga
    de Boer, Anthonius
    Groenwold, Rolf H. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1269 - 1276
  • [40] THE USE OF EXTERNAL DATA TO INFORM SURVIVAL EXTRAPOLATION IN ONCOLOGY TECHNOLOGY APPRAISALS: A COMPREHENSIVE REVIEW
    Reitsma, F.
    Pham, H. A.
    Heeg, B.
    VALUE IN HEALTH, 2022, 25 (01) : S179 - S180
12345